An Efficacy and Safety Study of PENTASA in Chinese Patients With Left-sided Active Ulcerative Colitis Followed by a 24-Week Open-Label Extension Phase

Condition:   Ulcerative ColitisInterventions:   Drug: Mesalazine Enema;   Drug: Placebo EnemaSponsor:   Ferring PharmaceuticalsRecruiting - verified April 2015

Source: ClinicalTrials.gov - February 16, 2015 Category: Research Source Type: clinical trials